Dawn Carter Bir - Net Worth and Insider Trading
Dawn Carter Bir Net Worth
The estimated net worth of Dawn Carter Bir is at least $6 Million dollars as of 2024-11-29. Dawn Carter Bir is the Chief Commercial Officer of Reata Pharmaceuticals Inc and owns about 33,805 shares of Reata Pharmaceuticals Inc (RETA) stock worth over $6 Million. Details can be seen in Dawn Carter Bir's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dawn Carter Bir has not made any transactions after 2023-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dawn Carter Bir
Dawn Carter Bir Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dawn Carter Bir owns 2 companies in total, including Geron Corp (GERN) , and Reata Pharmaceuticals Inc (RETA) .
Click here to see the complete history of Dawn Carter Bir’s form 4 insider trades.
Insider Ownership Summary of Dawn Carter Bir
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GERN | Geron Corp | 2019-03-26 | director |
| RETA | Reata Pharmaceuticals Inc | 2023-09-26 | Chief Commercial Officer |
Dawn Carter Bir Latest Holdings Summary
Dawn Carter Bir currently owns a total of 1 stock. Dawn Carter Bir owns 33,805 shares of Reata Pharmaceuticals Inc (RETA) as of August 16, 2023, with a value of $6 Million.
Latest Holdings of Dawn Carter Bir
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RETA | Reata Pharmaceuticals Inc | 2023-08-16 | 33,805 | 172.36 | 5,826,630 |
Holding Weightings of Dawn Carter Bir
Dawn Carter Bir Form 4 Trading Tracker
According to the SEC Form 4 filings, Dawn Carter Bir has made a total of 7 transactions in Reata Pharmaceuticals Inc (RETA) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Reata Pharmaceuticals Inc is the sale of 1,205 shares on August 16, 2023, which brought Dawn Carter Bir around $203,404.
Insider Trading History of Dawn Carter Bir
- 1
Dawn Carter Bir Trading Performance
Dawn Carter Bir Ownership Network
Dawn Carter Bir Owned Company Details
What does Geron Corp do?
Who are the key executives at Geron Corp?
Dawn Carter Bir is the director of Geron Corp. Other key executives at Geron Corp include EVP & Technical Operations Andrew J Grethlein , EVP & Corp Strategy & CCO Anil Kapur , and EVP & Chief Medical Officer Faye Feller .
Geron Corp (GERN) Insider Trades Summary
Over the past 18 months, Dawn Carter Bir made no insider transaction in Geron Corp (GERN). Other recent insider transactions involving Geron Corp (GERN) include a net sale of 674,348 shares made by Andrew J Grethlein , a net sale of 600,000 shares made by John A Scarlett , and a net sale of 421,875 shares made by Anil Kapur .
In summary, during the past 3 months, insiders sold 0 shares of Geron Corp (GERN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,984,123 shares of Geron Corp (GERN) were sold and 13,186 shares were bought by its insiders, resulting in a net sale of 1,970,937 shares.
Geron Corp (GERN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Geron Corp Insider Transactions
Dawn Carter Bir Mailing Address
Above is the net worth, insider trading, and ownership report for Dawn Carter Bir. You might contact Dawn Carter Bir via mailing address: C/o Reata Pharmaceuticals, Inc., 2801 Gateway Drive, Suite 150, Irving Tx 75063.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
